Cargando…

Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

BACKGROUND: The optimal follow-up strategy after curative thermal ablation of hepatocellular carcinoma (HCC) remains unclear. METHODS: We retrospectively analyzed a prospective series of 616 patients who underwent curative thermal ablation for HCC within the Milan criteria. Multivariate Cox model wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenwu, Zheng, Yun, Zou, Ruhai, Shen, Jingxian, He, Wei, Yang, Zhiwen, Zhang, Yuanping, Li, Binkui, Yuan, Yunfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267022/ https://www.ncbi.nlm.nih.gov/pubmed/30497418 http://dx.doi.org/10.1186/s12885-018-5069-z

Ejemplares similares

Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study
por: He, Wei, et al.
Publicado: (2018)

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence
por: Tao, Qiang, et al.
Publicado: (2018)

Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
por: Liu, Wenwu, et al.
Publicado: (2019)

Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
por: Liu, Wenwu, et al.
Publicado: (2019)

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature
por: Huang, Jun, et al.
Publicado: (2014)

Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study
por: Zeng, Qing-An, et al.
Publicado: (2012)

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
por: He, Wei, et al.
Publicado: (2015)

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2021)

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study
por: He, Wei, et al.
Publicado: (2020)

Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2017)

Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
por: Wang, Chenwei, et al.
Publicado: (2021)

Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
por: Liao, Yadi, et al.
Publicado: (2020)

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
por: Wang, Chenwei, et al.
Publicado: (2022)

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression
por: Zhong, Chengrui, et al.
Publicado: (2022)

The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
por: Sun, Xuqi, et al.
Publicado: (2019)

Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection
por: Adwan, Hamzah, et al.
Publicado: (2023)

Treatment of a huge biloma complicating curative radiofrequency ablation of hepatocellular carcinoma: a case report
por: Wang, Haochen, et al.
Publicado: (2019)

NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3
por: Zhang, Yuanping, et al.
Publicado: (2022)

Radiofrequency Ablation Combined with Resection Enhances Chance for Curative Treatment of Hepatocellular Carcinoma
por: Poon, Ronnie T. P.
Publicado: (2007)

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
por: Kim, Bo Hyun
Publicado: (2020)

Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence
por: Wang, Wei, et al.
Publicado: (2020)

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
por: Lee, Minjong, et al.
Publicado: (2018)

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
por: Yuan, Yichuan, et al.
Publicado: (2023)

Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram
por: Yuan, Chunwang, et al.
Publicado: (2019)

Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation
por: Li, Yifan, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation
por: Hu, Shuifang, et al.
Publicado: (2022)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment
por: Ohama, Hideko, et al.
Publicado: (2022)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
por: Ma, Hui, et al.
Publicado: (2021)

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
por: Qiu, Jiliang, et al.
Publicado: (2011)

Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis
por: Luo, Wen, et al.
Publicado: (2017)

Computed Tomography and Ultrasounds for the Follow-up of Hepatocellular Carcinoma Ablation: What You Need to Know
por: Kelekis, Alexios, et al.
Publicado: (2016)

Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification
por: Sun, Xuqi, et al.
Publicado: (2020)

Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy
por: Eletreby, Rasha, et al.
Publicado: (2023)

Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
por: Qiu, Zhiyu, et al.
Publicado: (2021)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy
por: Guo, Zhe, et al.
Publicado: (2015)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
por: Lee, Soon Kyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9jmppdfgtt46r998rnbutv67r